Your browser doesn't support javascript.
loading
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer.
Li, Song; Yu, Wenbin; Xie, Fei; Luo, Haitao; Liu, Zhimin; Lv, Weiwei; Shi, Duanbo; Yu, Dexin; Gao, Peng; Chen, Cheng; Wei, Meng; Zhou, Wenhao; Wang, Jiaqian; Zhao, Zhikun; Dai, Xin; Xu, Qian; Zhang, Xue; Huang, Miao; Huang, Kai; Wang, Jian; Li, Jisheng; Sheng, Lei; Liu, Lian.
Afiliação
  • Li S; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Yu W; Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Xie F; Department of Pharmacy, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Luo H; Shenzhen Yucebio Technology Co., Ltd., Shenzhen, 518000, Guangdong, China.
  • Liu Z; Department of General Surgery, Zibo Municipal Central Hospital, Binzhou Medical College, Zibo, 255036, Shandong, China.
  • Lv W; Department of Radiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Shi D; Department of Pathology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Yu D; Department of Radiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Gao P; Department of Pathology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Chen C; Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Wei M; Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Zhou W; Shenzhen Yucebio Technology Co., Ltd., Shenzhen, 518000, Guangdong, China.
  • Wang J; Shenzhen Yucebio Technology Co., Ltd., Shenzhen, 518000, Guangdong, China.
  • Zhao Z; Shenzhen Yucebio Technology Co., Ltd., Shenzhen, 518000, Guangdong, China.
  • Dai X; Department of Medical Oncology, Shandong Provincial Hospital of Traditional Chinese Medicine, Jinan, 250012, China.
  • Xu Q; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Zhang X; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Huang M; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Huang K; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Wang J; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Li J; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Sheng L; Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Liu L; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China. lianliu@sdu.edu.cn.
Nat Commun ; 14(1): 8, 2023 01 03.
Article em En | MEDLINE | ID: mdl-36596787
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Inibidores de Checkpoint Imunológico Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Inibidores de Checkpoint Imunológico Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China